Drugs / CPP-ACPF
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable2 trials | ||||||
| — | NCT07653373 | Aug 2026 → Dec 2027 expected | — | Universidade Ceuma | Not yet recruiting | No outcome recorded |
| — | NCT07506850 | Feb → Jul 2025 | dentin sensitivity | Federal University of Pará | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT05298059 Comparator | Mar → Apr 2022 | dentin sensitivity | Federal University of Pará | Completed | No outcome recorded |
| — | NCT03391180 Comparator | Feb → Apr 2018 | — | Riyadh Colleges of Dentistry and Pharmacy | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CPP-ACPF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07653373 ↗ |
| Known as | MI Paste Plus | “1. CPP-ACP with sodium fluoride (MI Paste Plus),” NCT07506850 ↗ |